ENVALITH
協和キリン株式会社 logo

Kyowa Kirin Co., Ltd.

4151Prime MarketPharmaceuticals

協和キリン株式会社 logo
Kyowa Kirin Co., Ltd.4151
Reference Indicators

Market Cap

13,932¥100M

P/E (Forecast)

18.5x

P/B

1.6x

Dividend Yield (Forecast)

2.64%

ROE

7.5%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
352,246398,371442,233495,558496,826
Cost of Sales
87,84986,915111,207132,611127,934
Gross Profit
264,398311,455331,026362,947368,892
SG&A Expenses
145,608166,185163,078167,537165,434
Pre-tax Income
60,05067,57297,24683,45387,221
Income Taxes
7,70314,00016,05823,58320,182
Net Income
52,34753,57381,18859,87067,040
Gross Margin
75.1%78.2%74.9%73.2%74.2%
ROA
5.7%5.7%7.9%5.6%6.1%
ROE
7.1%7.0%9.7%7.0%7.5%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
医薬000.0%